These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 28155566)
1. In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma. Yu Y; Xu S; You H; Zhang Y; Yang B; Sun X; Yang L; Chen Y; Fu S; Wu J Drug Deliv; 2017 Nov; 24(1):75-82. PubMed ID: 28155566 [TBL] [Abstract][Full Text] [Related]
2. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma. You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation. Hu J; Fu S; Peng Q; Han Y; Xie J; Zan N; Chen Y; Fan J Int J Pharm; 2017 Jan; 516(1-2):313-322. PubMed ID: 27884713 [TBL] [Abstract][Full Text] [Related]
4. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Xu C; Liu W; Hu Y; Li W; Di W Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871 [TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747 [TBL] [Abstract][Full Text] [Related]
7. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells. Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046 [TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076 [TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer. Lv W; Cheng L; Li B Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039 [TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
11. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677 [TBL] [Abstract][Full Text] [Related]
12. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy. Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247 [TBL] [Abstract][Full Text] [Related]
13. An injectable thermosensitive hydrogel self-supported by nanoparticles of PEGylated amino-modified PCL for enhanced local tumor chemotherapy. Guo J; Feng Z; Liu X; Wang C; Huang P; Zhang J; Deng L; Wang W; Dong A Soft Matter; 2020 Jun; 16(24):5750-5758. PubMed ID: 32529197 [TBL] [Abstract][Full Text] [Related]
14. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy. Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167 [TBL] [Abstract][Full Text] [Related]
15. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Wang C; Wang Y; Wang Y; Fan M; Luo F; Qian Z Int J Pharm; 2011 Jul; 414(1-2):251-9. PubMed ID: 21596124 [TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma. Pei Q; Hu X; Liu S; Li Y; Xie Z; Jing X J Control Release; 2017 May; 254():23-33. PubMed ID: 28359677 [TBL] [Abstract][Full Text] [Related]
19. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
20. HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma. Peng J; Zhao J; Zhao Y; Wu P; Gou L; Fu S; Chen P; Lu Y; Yang L Int J Nanomedicine; 2020; 15():6409-6420. PubMed ID: 32922008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]